REQUEST A DEMO
Total
USD $0.00
Search more companies

Fertimedex S.A.S. (Ecuador)

Main Activities: Offices of Physicians
Secondary Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Fertimedex S.A.S. Profile Updated: June 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Fertimedex S.A.S. is a company in Ecuador, with a head office in Quito. The company operates in the Offices of Physicians sector. Fertimedex S.A.S. was incorporated on August 07, 2022. The total number of employees is currently 2 (2023). The latest financial highlights indicate a net sales revenue increase of 1010.48% in 2023. Over the same period, its total assets decreased by 35.03%. The enterprise’s net profit margin increased by 0.06% in 2023.

Headquarters
Eloy Alfaro N29-235, Edificio Fortune Plaza Medical Bldg. , Floor 4
Quito; Pichincha;

Contact Details: Purchase the Fertimedex S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Fertimedex S.A.S. report to view the information.
Outstanding Shares:
Purchase the Fertimedex S.A.S. report to view the information.
Registered Capital:
Purchase the Fertimedex S.A.S. report to view the information.
Incorporation Date:
August 07, 2022
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Fertimedex S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
1010.48%
Total operating revenue
1010.48%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
2286.6%
Total assets
-35.03%
Total equity
23.63%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
0.06%
Return on Equity (ROE)
18.12%
Quick Ratio
0.35%
Cash Ratio
0.67%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?